Boddu PC, Senapati J, Ravandi-Kashani F, Jabbour EJ, et al. A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies. Cancer 2023;129:580-589.
PMID: 36448227